Director/PDMR Shareholding

RNS Number : 8836Q

Hikma Pharmaceuticals Plc

02 December 2016

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

The attached individual notification made under article 19.1 of the Market Abuse Regulation ("MAR") relates to the purchase by Darhold Limited of Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. The Chairman and Chief Executive, Vice Chairman and a Non-executive Director are directors of and shareholders in Darhold Limited. This announcement is made in accordance with article 19.3 of MAR.

Said Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Said Darwazah
2	Reason for the notification
a)	Position/status	Chairman and Chief Executive Officer / PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Acquisition by Darhold Limited of 150,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. The Chairman and Chief Executive is a director of and shareholder in Darhold Limited with an equity interest of 21.67%.
c)	Price(s) and volume(s)	Price(s): £17.02 Volume(s): 50,000 Price(s): £16.74 Volume(s): 50,000 Price(s): £16.62 Volume(s): 50,000
d)	Aggregated information	Aggregated volume: 150,000 Price: £16.79
e)	Date of the transaction	30 November, 1 December and 2 December 2016
f)	Place of the transaction	London Stock Exchange (XLON)

 Mazen Darwazah

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mazen Darwazah
2	Reason for the notification
a)	Position/status	Executive Vice Chairman / PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Acquisition by Darhold Limited of 10,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. The Executive Vice Chairman is a director of and shareholder in Darhold Limited with an equity interest of 10.92%.
c)	Price(s) and volume(s)	Price(s): £17.02 Volume(s): 50,000 Price(s): £16.74 Volume(s): 50,000 Price(s): £16.62 Volume(s): 50,000
d)	Aggregated information	Aggregated volume: 150,000 Price: £16.79
e)	Date of the transaction	30 November, 1 December and 2 December 2016
f)	Place of the transaction	London Stock Exchange (XLON)

Mohammed 'Ali' Al-Husry

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mohammed 'Ali' Al-Husry
2	Reason for the notification
a)	Position/status	Non-executive Director/ PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Acquisition by Darhold Limited of 10,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. The Non-Executive Director is a director of and shareholder in Darhold Limited with an equity interest of 8.01%.
c)	Price(s) and volume(s)	Price(s): £17.02 Volume(s): 50,000 Price(s): £16.74 Volume(s): 50,000 Price(s): £16.62 Volume(s): 50,000
d)	Aggregated information	Aggregated volume: 150,000 Price: £16.79
e)	Date of the transaction	30 November, 1 December and 2 December 2016
f)	Place of the transaction	London Stock Exchange (XLON)

Peter Speirs, Company Secretary, Responsible for releasing this announcement

2 December 2016

 

END

 

 

DSHBRBDDCXGBGLD